Interviews

Researchers explore a promising nonchemotherapy treatment for low-grade serous ovarian cancer, combining ribociclib and letrozole to improve patient outcomes.

Cervical cancer treatment evolves with molecular screening and immunotherapies, emphasizing early detection as key to improving patient outcomes.

Roberto Mina, MD, associate professor of hematology at the Winship Cancer Institute at Emory University, discussed the significance of the patient population of the MajesTEC-9 trial in patients with relapsed/refractory multiple myeloma.

Experts discuss optimizing NALIRIFOX treatment for metastatic pancreatic cancer, highlighting flexible dosing and early adverse event recognition for better patient outcomes.

In an interview with Targeted Oncology, George Mulligan, PhD, discussed the key takeaways from analysis of the Immune Atlas for multiple myeloma and what will come next now that this data set has been made available.

Rebecca Siegel, MPH, highlights alarming cancer disparities among American Indian, Alaska Native, and Black populations, emphasizing systemic issues over individual choices.

Roberto Mina, MD, discussed the significance of the early outcomes that were reported from the MajesTEC-9 trial in patients with relapsed/refractory multiple myeloma.

Recent cancer statistics reveal significant survival rate improvements for aggressive cancers, highlighting advancements in treatment and a shift in oncology outcomes.

Dr. Lucio N. Gordan advocates for healthcare reform to protect community oncology, emphasizing site parity and 340B program changes to reduce financial toxicity.

Community oncology significantly reduces cancer care costs while maintaining quality, offering a sustainable solution to financial toxicity for patients.

Lucio N. Gordan discusses the economic burden of financial toxicity in oncology, highlighting its impact on patients and the healthcare system.

Rebecca Siegel, MPH, reveals key insights on lung cancer trends, survival rates, and the need for targeted interventions in diverse populations.

Explore how community oncology reduces financial toxicity in cancer care, highlighting cost savings and quality benefits over hospital-based systems.

Explore the complexities of HPV status in head and neck cancer treatment, emphasizing the importance of accurate patient selection and evidence-based practices.

Experts discuss a virtual collaborative care model that integrates mental health support into oncology, enhancing patient care and improving treatment outcomes.

Jason S. Starr, DO, discusses his approach to dose reduction of cabozantinib in patients with neuroendocrine tumors.

Researchers explore the impact of virtual collaborative care on mental health and quality of life for breast cancer patients, revealing significant improvements.

Experts explore a virtual collaborative care model to enhance mental health support for breast cancer patients, aiming to improve treatment adherence and outcomes.

Research on myeloma shows significant progress in treatment options, emphasizing the need for early detection and access to care for affected communities.

Giredestrant shows lower treatment discontinuation rates compared to standard therapy and is being explored in combination with other drugs.

Dena Champion leads a transformative initiative for cancer survivors, blending nutrition, community, and gardening to promote health and well-being.

Digital pathology revolutionizes diagnostics with AI and imaging, enhancing accuracy, speed, and personalized medicine for improved patient care.

Dr Benjamin George champions innovative oncology care in rural Nebraska, emphasizing collaboration and multidisciplinary teamwork to enhance patient outcomes.

Dr Benjamin George transforms oncology care in rural Nebraska, addressing unique challenges and enhancing access to vital treatments for underserved patients.

Dr Benjamin George champions accessible cancer care in rural Nebraska, transforming patient support with innovative programs and community engagement.

Dr Benjamin George transforms cancer care in rural Nebraska, ensuring accessible, high-quality treatment for patients in underserved communities.

Benjamin George, MD, combines compassionate oncology care with cutting-edge science, fostering deep patient relationships and offering hope through advanced treatments.

Explore how thalidomide derivatives enhance T-cell responses and combat exhaustion in multiple myeloma therapies for improved patient outcomes.

New research highlights nivolumab AVD as a promising new standard of care for advanced Hodgkin lymphoma, showing improved survival rates and tolerability.